Targeting c-FLIP in cancer.

Abstract : Cellular-FLICE inhibitory protein (c-FLIP) is a key anti-apoptotic regulator that inhibits cell death mediated by the death receptors Fas, DR4, DR5, and TNF-R1. Three splice variants of c-FLIP function at the DISC level by blocking the processing and activation of procaspase-8 and -10. Overexpression of c-FLIP has been identified in many different tumour types, and its downregulation in vitro has been shown to restore apoptosis mediated by CD95L and TRAIL. c-FLIP therefore represents a promising target for cancer therapy. This review focuses on the molecular mechanisms that control c-FLIP expression and current research into inhibitors of the protein. Increasing evidence supports the investigation of c-FLIP as a therapeutic target to restore an apoptotic response in cancer cells.
Type de document :
Article dans une revue
Cancer Letters, Elsevier, 2013, 332 (2), pp.141-50. 〈10.1016/j.canlet.2010.10.009〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00525448
Contributeur : Olivier Micheau <>
Soumis le : lundi 15 novembre 2010 - 10:36:41
Dernière modification le : dimanche 11 février 2018 - 01:14:44
Document(s) archivé(s) le : vendredi 2 décembre 2016 - 00:27:01

Fichiers

Sarah-figures.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Sarah Shirley, Olivier Micheau. Targeting c-FLIP in cancer.. Cancer Letters, Elsevier, 2013, 332 (2), pp.141-50. 〈10.1016/j.canlet.2010.10.009〉. 〈inserm-00525448〉

Partager

Métriques

Consultations de la notice

387

Téléchargements de fichiers

659